Protein Design Labs receives license fees for humanized antibodies.(Protein Design Labs, Inc., Genentech, Inc.'s Xolair and RAPTIVA antibody products): An article from: BIOTECH Patent News

This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on February 1, 2004. The length of the article is 1577 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Protein Design Labs receives license fees for humanized antibodies.(Protein Design Labs, Inc., Genentech, Inc.'s Xolair and RAPTIVA antibody products)
Publication:BIOTECH Patent News (Newsletter)
Date: February 1, 2004
Publisher: Biotech Patent News
Volume: 18 Issue: 2

Distributed by Thomson Gale